Ethics and evidence in clinical trials

被引：6

作者：

Goodman, SN ^{[1
]}

机构：

[1] Johns Hopkins Univ, Baltimore, MD 21218 USA

来源：

CLINICAL TRIALS | 2005年 / 2卷 / 03期

关键词：

D O I：

10.1191/1740774505cn083ed

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：195 / 196

页数：2

共 13 条

[1] Where's the utility in Bayesian data-monitoring of clinical trials? [J].

Ashby, D ;

Tan, SB .

CLINICAL TRIALS, 2005, 2 (03) :197-205

[2]

Chalmers I, 2005, CLIN TRIALS, V2, P229

[3] The use of systematic reviews when designing studies [J].

Cooper, NJ ;

Jones, DR ;

Sutton, AJ .

CLINICAL TRIALS, 2005, 2 (03) :260-264

[4] Randomized controlled trials of aprotinin in cardiac surgery: could clinical equipoise have stopped the bleeding? [J].

Fergusson, D ;

Glass, KC ;

Hutton, B ;

Shapiro, S .

CLINICAL TRIALS, 2005, 2 (03) :218-229

[5] A critical history of individual and collective ethics in the lineage of Lellouch and Schwartz [J].

Heilig, CM ;

Weijer, C .

CLINICAL TRIALS, 2005, 2 (03) :244-253

[6] Abstracts presented at the American Society of Clinical Oncology conference: how completely are trials reported? [J].

Hopewell, S ;

Clarke, M .

CLINICAL TRIALS, 2005, 2 (03) :265-268

[7]

London AJ, 2000, J MED PHILOS, V25, P379, DOI 10.1076/0360-5310(200008)25:4

[8]

1-A

[9]

FT379

[10] Equipoise in the enhanced supression of the platelet Ilb/IIIa receptor with Integrilin Trial (ESPRIT): a critical appraisal [J].

Mann, H ;

London, AJ ;

Mann, J .

CLINICAL TRIALS, 2005, 2 (03) :233-241

← 1 2 →